interleukin-6 Archives - Biotech Primer WEEKLY

Nanobodies: These Are Not Your Mother’s mAbs

by Stacey Hawkins | May 25, 2017 | Immunotherapies

The Drug Kingpins Monoclonal antibodies (mAbs) are the undisputed drug kingpins. In 2013, the mAb market raked in $75 billion in combined sales, covering a whole range of indications from cancer and infectious disease, to autoimmune disorders, and even high...

Nanobodies: These Are Not Your Mother’s mAbs

About Biotech Primer

Subscribe to The WEEKLY